Abstract The role that genetics play in response to infection or disease is becoming increasingly clear as we learn more about immunogenetics and host-pathogen interactions. Here we report a genome-wide analysis of the effects of host genetic variation on cytokine responses to vaccinia virus stimulation in smallpox vaccine recipients. Our data show that vaccinia stimulation of immune individuals results in secretion of inflammatory and Th1 cytokines. We identified multiple SNPs significantly associated with variations in cytokine secretion. These SNPs are found in genes with known immune function, as well as in genes encoding for proteins involved in signal transduction, cytoskeleton, membrane channels and ion transport, as well as others with no previously identified connection to immune responses. The large number of significant SNP associations implies that cytokine secretion in response to vaccinia virus is a complex process controlled by multiple genes and gene families. Follow-up studies to replicate these findings and then pursue mechanistic studies will provide a greater understanding of how genetic variation influences vaccine responses.
Introduction
Smallpox, a deadly disease caused by variola virus, plagued mankind until a decades-long effort by the World Health Organization led to its eradication in 1980 (Fenner 1988) . Edward Jenner pioneered the use of cross-protective poxviruses as safe and effective vaccines (Jenner 1798) . This work led to the eventual development of the vacciniabased vaccines used successfully in the eradication effort. These live viral vaccines not only induced high levels of humoral and cell-mediated immunity in vaccinated subjects (Combadiere et al. 2004; Crotty et al. 2003; Frey et al. 2002; Hammarlund et al. 2003; Kennedy et al. 2009b ), but also caused adverse events, some of which were lifethreatening (Fulginiti 2003; Fulginiti et al. 2003) , and resulted in the cessation of routine vaccination shortly after endemic smallpox was eradicated. A large percentage of the current US population have conditions that contraindicate receipt of the vaccine (immunosuppression due to: cancer, organ transplants, HIV infection, heart conditions, and skin diseases such as eczema or psoriasis) (Fenner 1989) . Altered cytokine responses to vaccinia inoculation in individuals with atopic dermatis are believed to be responsible for the higher incidence of eczema vaccinatum (Grigoryev et al. 2010; Howell et al. 2006; Scott et al. 2007 ). Furthermore, Th2 responses are correlated with impaired viral clearance , while animal models where expression of key cytokines are intentionally over-or under-expressed clearly indicate that cytokine production in response to poxvirus infection or inoculation can greatly influence the course of the viral infection (Foong et al. 2009; Kohyama et al. 2007; Sharma et al. 1996; Tian et al. 2009; van Den Broek et al. 2000) . Genetic variations can have a profound influence on disease susceptibility, progression, and resolution, as well as on vaccine-induced immune responses. Here we present data on genome-wide SNPs associated with variations in cytokine responses in a well characterized cohort of over 1,000 healthy adult recipients of the smallpox vaccine. Identifying the genetic elements controlling cytokine secretion in response to viral infection or vaccination will assist in creation of next-generation vaccines that elicit immune responses with the optimal Th1/Th2 balance, as well as other cytokines (Th17, inflammatory cytokines) necessary for robust immune protection.
Materials and methods

Subject recruitment
Study subjects were recruited from military personnel who were recent recipients of a single dose of the Dryvax Ò smallpox vaccine and from civilian healthcare workers who participated in the civilian smallpox immunization program at the Mayo Clinic in Rochester, MN. Military personnel were recruited from the Naval Health Research Center (NHRC) in San Diego, CA (Kennedy et al. 2009a ). All participants were in good general health, had received one, and only one, dose of the smallpox vaccine within the past four years and had a documented vaccine ''take,'' indicating successful immunization. Approval from the Institutional Review Boards of both the Mayo Clinic and NHRC was obtained, as was written informed consent from each subject prior to all study procedures.
Isolation of peripheral blood mononuclear cells (PBMC)
Each subject underwent a single blood draw of approximately 100 mL, with blood collected in heparinized tubes and shipped overnight at room temperature. PBMCs from each subject were isolated within 24 h of blood draw using Accuspin (Sigma, St. Louis, MO) tubes containing HISTOPAQUE Ò -1077 (Sigma) according to established procedures. Isolated PBMCs (1 9 10 7 cells/mL) were resuspended in culture medium supplemented with 10 % dimethyl sulfoxide (Protide Pharmaceuticals, St. Paul, MN) and 20 % fetal bovine serum (FBS; Hyclone, Logan, UT), frozen for 18 h in controlled-rate freezing containers, and in liquid nitrogen for long-term storage (Ryan et al. 2009 ).
SNP typing and QC
The Gentra Puregene Blood kit (Gentra Systems Inc., Minneapolis, MN) was used to extract DNA from biospecimens prior to quantification by Picogreen (Molecular Probes, Carlsbad, CA). Genome-wide SNP typing was performed using the Infinium HumanHap550 or HumanHap650Y BeadChip arrays for the Caucasian and African-American subjects, respectively. After whole genome amplification, fragmentation and hybridization, samples were imaged on an Illumina BeadArray reader. The genotyping module of BeadStudio 2 was used to make the clustering and genotyping calls, which were then transferred to a SAS database for later analyses. Quality control checks included: genotyping reproducibility using paired samples, removal of monomorphic SNPs, call rate cutoffs of \95 % for both individual SNPs and subjects, and a check for Hardy-Weinberg equilibrium (HWE). As subjects from two races were genotyped, tests for deviation from HWE were performed in a race-stratified fashion similar to the exact test of (Schaid et al. 2006 ).
ELISA assays
Frozen PBMC aliquots were recovered as previously described (Ovsyannikova et al. 2005; Ryan et al. 2009 ). Briefly, cells were thawed and resuspended in culture medium supplemented with 50 IU/ml of IL-2 (Proleukin Ò , Chiron, Emeryville, CA) overnight. After washing, cells were resuspended at a concentration of 2 9 10 6 cells/mL for use in the cytokine secretion assays.
Vaccinia virus (NYCBOH) was grown and titered according to established procedures (Earl et al. 2001; Kennedy et al. 2009a) . A single viral stock was prepared for all assays and was inactivated using psoralen and UV light to minimize viral modulation of immune responses (Ryan et al. 2009 ).
2 9 10 5 PBMCs were plated in each well of 96-well round-bottom plates. Experimental conditions included: a single well containing PHA (5 ug/ml) as a positive control, triplicate wells containing culture medium (unstimulated wells), and triplicate wells with vaccinia virus (stimulated wells). Cytokine-specific vaccinia stimulation was optimized based on multiplicity of infection (MOI) and length of time in culture as previously described (Ryan et al. 2009 ) and is as follows: IFNb, IL-2, IL-18: MOI = 5, 24 h; IL-12p40, IL-12p70, TNFa, IL-1b: MOI 0.5, 24 h; IFNa: MOI = 0.05, 4 days; IL-4, IL-10: MOI = 0.05, 7 days; IL-6: MOI = 5, 8 days.
Cytokine levels in culture supernatant were detected using commercial ELISA-based kits for IL-1b, IL-2, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-a (all from BD Pharmingen), IFN-a (PBL Biomedical Laboratories, Piscataway, NJ), IFN-b (PBL Biomedical Laboratories), and IL-18 (MBL International, Woburn, MA). Optical density readings at 450 nm were converted to cytokine concentrations in pg/ml using the reference standards included in each assay.
Population stratification
As study participants were of more than one race, we selected 22,863 SNPs with [99 % call rates that were spaced at approximately 100 kb intervals and used these SNPs in the principal components (PC) implemented in the Eigenstrat software package to assess population structure (Price et al. 2006) . Using the same genotype data, we employed a clustering procedure similar to what is implemented in the Structure software program (Pritchard et al. 2000) to assign Caucasian or African-American racial group membership to subjects who had not self-reported a conclusive racial declaration. After defining genetic racial groups, we extracted the first four Eigenstrat axes of variation (Price et al. 2006) within each group and used these as covariates in the race-specific analyses to account for residual population stratification.
Statistical analyses
These analytical methods are identical to those employed in our other genome-wide association study of smallpox vaccine response. Assessment of cytokines resulted in six recorded values: those from the three unstimulated and the three vaccinia stimulated wells. The median of the unstimulated wells was subtracted from the median value of the stimulated wells to create a summary measure of each cytokine secretion level for each individual.
Associations between the levels of each cytokine level and the SNP genotypes were assessed separately within the two racial groups using linear regression models. SNPs were modeled assuming an additive genotypic effect. Formal evaluations of significance utilized repeated measures analyses that used all of the multiple observations per subject while accounting for within-subject correlations using generalized estimating equations (GEEs). As there were measurements of cytokine levels in both the stimulated and unstimulated state for each individual, the primary test for genetic association between a SNP and the outcome of interest was a test for interaction between the ordinal SNP variable and a variable identifying whether the result arose from a stimulated or an unstimulated state. The tests of the significance of these interactions are similar to paired t tests: both compare differences in the two stimulation states within an individual among genotypedefined groups of individuals. All analyses adjusted for gender; age at blood draw (quartiles); time from smallpox immunization to blood draw (quartiles); time from blood draw to assay (quartiles); shipping temperature of the sample (frozen or ambient); time of year when the sample was shipped (warm-weather months April-September vs. cold-weather months October-March); and the first four Eigenstrat axes of variation. An inverse cumulative normal (probit) transformation was used for the cytokine variables to correct for data skewness. We used q-q plots to compare the observed and expected distribution of p values for a given outcome across all SNPs. Genomic control lambda values were calculated to assess, and correct for, any potential residual inflation of significance in the race-specific results. All statistical tests were twosided, and were performed using the R software package (unless otherwise indicated) (Team 2008) . Due to the existence of several significant SNPs for which few subjects had two copies of the minor allele, additional models were run to further assess the effect of the minor alleles. These sensitivity analyses involved grouping the homozygous minor subjects with the heterozygous subjects, resulting in a dominant rather than an ordinal model. The models were run with the same adjusting factors as the ordinal model.
Results
SNP typing results
Subjects were genotyped using the Illumina Infinium HumanHap550 (Caucasians) or the HumanHap 650Y (African-American) BeadChip arrays. The HumanHap550 is a subset of SNPs from the HumanHap650Y; the following summary is for all SNPs, with the understanding that some SNPs were only run for the African-American subjects. Overall genotype concordance was high (97.9 % including missing genotypes, 99.9 % after excluding missing genotypes). SNPs with call rates below 95 % were excluded (7.3 %), as were 71 subjects with call rates \95 %. Additional exclusions involved removing SNPs with minor allele frequencies below 1 % and those that appeared to be out of HWE (p \ 10 -8 ). Of these 1,000 subjects, 580 formed the Caucasian racial cluster and 217 formed the African-American cluster. During analysis, SNPs with fewer than 10 observed minor alleles for a given outcome and racial cohort (Caucasian or AfricanAmerican) were excluded from that outcome/race specific analysis.
Immune outcomes
Cytokine responses for each subject were quantitated by ELISA assays and are outlined in (Umlauf et al. 2011) . In contrast, we saw low levels of IL-10 and negligible amounts of IL-4, IL-12p70, IL-18, and IFNb. Although we did find statistically significant associations for IL-4, IL-12p70, IL-18, and IFNb, the small differences in cytokine secretion are unlikely to be biologically meaningful; therefore results from these cytokines are not reported.
Genome-wide analysis results
Our results indicated that recall responses in smallpox vaccine recipients are primarily Th1 and that viral stimulation also induces a strong proinflammatory response in PBMCs. We found a number of significant genetic associations with variations in Th1-type cytokine production. After correction for the small degree of inflation of significance present in the p value distributions, a number of SNPs for the phenotypes of interest were identified as meeting initial thresholds of significance. The Q-Q-plots and Manhattan plots indicating associations with IL-2 secretion for both our Caucasian and African-American cohorts are illustrated in Fig. 1 . SNP associations with Th1 cytokine secretion (IL-2, TNFa, IL-12p40) that reached a high level of significance (p \ 5 9 10 -7 ) are listed in Tables 2 and 3 for Caucasians and African Americans, respectively. Tables 4, 5 and 6 outline the significant associations found with the pro-inflammatory cytokines IL-1b, IFNa, and IL-6, respectively. Table 7 documents the genetic associations for IL-10, the only Th2 cytokine that was consistently secreted upon viral stimulation of PBMCs from vaccinated subjects. For each of the tables, we have listed the function of the protein product (where known) underneath the gene name.
Discussion
Both animal models and large-scale vaccination studies have demonstrated that poxviruses elicit a strong Th1 response. Our results indicate that this Th1 response is maintained in the vaccinia virus-specific memory T cell population as well. We have previously reported on genome-wide associations with markers of cellular immunity, namely IFNc ELISPOT and quantitation of secreted IFNc: in this report we extend our findings to additional measures including Th1, Th2, and inflammatory cytokines. Interestingly, we found considerable variations in cytokine responses to viral stimulation of PBMCs from vaccinated individuals ( Table 1) .
The relative absence of IFNb or IL-18 secretion by PBMCs in response to vaccinia infection may be due to the immunomodulatory proteins encoded by poxviruses such as those described below. We inactivated the virus stock used in our experiments with psoralen and UV irradiation to crosslink viral DNA, resulting in [6 log reduction in infectivity. It is likely that this treatment inhibited viral production of immunomodulatory proteins (and we have previously reported on the detection of IFNg using live vs inactivated vaccinia virus) (Ryan et al. 2009 ); however, we cannot rule out the possibility that NYCBOH-encoded proteins (A52R, A53R, B13R, B16R, B19R, C12L) affected secretion patterns of the cytokines assayed. A53R encodes CrmC, a soluble TNFR protein capable of sequestering TNFa and inhibiting TNF signaling. The NYCBOH genome also contains two additional genes for Immune outcome measurements in each racial cohort following stimulation with vaccinia virus soluble TNFR proteins (C22L, B28R), although they contain mutations and are likely nonfunctional (Goebel et al. 1990 ). Some strains of vaccinia (Lister, USSR, Evans) also contain the K3R gene which encodes CrmE, yet another soluble TNFR (Alcami et al. 1999; Reading et al. 2002) . The B19R glycoprotein is a soluble receptor for IFN a/b, inhibiting IFNa/b from binding to cellular receptors and dampening antiviral responses (Colamonici et al. 1995; Symons et al. 1995) . The E3L protein binds to dsRNA and inhibits PKR signaling (Chang et al. 1992) , IRF-dependent type I IFN synthesis, and TNFa production (Myskiw et al. 2009; Smith et al. 2001) . Vaccinia viruses, including the NYCBOH strain, also encode C12L, which is an IL-18 binding protein that inhibits IL-18 receptor activation, and may have hampered antibody-based detection of IL-18 in culture supernatant (Reading and Smith 2003; Smith et al. 2000; Symons et al. 2002) . NYCBOH also encodes both B16R (an IL-1b inhibitor) and C10L (an IL-1R antagonist), which both block IL-1b signaling. We found high levels of TNFa, IFNa, IFNc, and IL-1b in spite of the virally encoded immunomodulatory proteins affecting each of these cytokines, providing support for our hypothesis that viral proteins are not interfering with cytokine secretion. Although the median concentration of secreted IL-18 was low (0.7 pg/ml in Caucasians and 1.3 pg/ml in African-Americans), we have previously reported a number of SNPs in both IL18 and IL18R that are significantly associated with vaccinia neutralizing antibody titer after smallpox immunization . Our analyses here have focused on the entire cohort, and it is quite possible that subsets of our cohort (for example: those making larger quantities of IL-18) behave differently from the group as a whole, and thus more focused studies may provide novel insights into the genetic control of smallpox vaccine responses.
One of the strengths of genome-wide association studies is the ability to identify novel genes/processes involved in control of diseases or biologic responses. Our results indicate that a large number of SNPs were associated with variations in cytokine response to vaccinia virus in subjects who had received the smallpox vaccine. One such SNP is rs16948200 in the nerve growth factor receptor gene NGFR. African-American individuals homozygous for the major allele (G) secrete over 12-fold more IL-2 than heterozygotes, while those homozygous for the minor allele (A) secrete essentially no IL-2. NGFR shares a similar structure to other members of the TNFR superfamily including the involvement of the downstream NF-kB and apoptotic pathways (Lotz et al. 1996) . Nerve growth factor is produced by a variety of lymphoid cells and can influence proliferation, survival, differentiation, and effector function immune cells (Garaci et al. 1999; Lambiase et al. 1997; Otten et al. 1989; Torcia et al. 1996) . Our results indicate a possible connection between NGFR and IL-2, which may account for the proliferative and survival effects of NGF on immune cells. The intronic SNP rs4251424, in the interleukin-1 receptor-associated kinase 4 (IRAK4) gene, was associated with differential secretion of TNFa. In fact, African-Americans homozygous for the major allele (G) secreted nearly twice as much TNFa as heterozygous individuals. IRAK4 initiates a cascade of phosphorylation and signaling events in response to viral stimulation through TLRs (TLR7, 8, and 9), resulting in cytokine production (Yang et al. 2005) . IRAK4 has also been implicated in T cell activation and function (Suzuki et al. 2006 ). Thus, a SNP influencing IRAK4 expression or function may lead to distinct differences in T cell production of TNFa. Rs11242417, an intronic SNP in the glial cell linederived neurotrophic factor receptor alpha (GFRA3) gene, is associated with variations in IL-12p40 secretion in our Caucasian cohort. The GFRA3 gene encodes for a cellular receptor involved in neuronal development (Nishino et al. 1999) and although this same SNP is associated with schizophrenia (Souza et al. 2010) , its role in immune function is not known. In our African-American cohort, we identified rs859267 in ADORA2B as being associated with variations in IL-12p40 in an allele dose-dependent manner. Possession of the minor allele (C) leads to a 30 % reduction in IL-12p40 for heterozygotes and a 70 % reduction in IL-12p40 secretion in homozygotes (Table 8) . ADORA2B encodes for the adenosine A2B G protein coupled receptor. Blockade of ADORA2B signaling enhances macrophage phagocytosis, cytokine production, and chemokine synthesis (Belikoff et al. 2011) . Adenosine also inhibits IL-12 and TNFa release by dendritic cells through activation of the adenosine A2 receptor (Ben Addi et al. 2008; Panther et al. 2003) , providing supporting evidence for our results showing that genetic polymorphisms in ADORA2B may affect IL-12 production by PBMCs.
IFNa production was also significantly associated with a number of SNPs in both of the racial groups we studied. In Caucasian subjects, possession of a single minor allele (A) at rs542631 in the LTBP1 gene led to a 260 % increase in IFNa secretion upon vaccinia stimulation. LTBP1 is involved in the trafficking and activation of latent TGFB complexes (Keski-Oja et al. 2004) . Our data also show that another SNP near the same gene, rs6728024, is associated with variations in IL-6 secretion in African-American subjects, resulting in an almost three-fold, minor allele dose-dependent increase of IL-6. These associations are not surprising given the myriad effects TGF-b can have on cytokine production by immune cells, including the induction of proinflammatory cytokines (TNFa, IL-1, IL-6) 7 (100.9,212.5) by monocytes (Bogdan and Nathan 1993) . We also found a number of SNPs significantly associated with IFNa secretion in our African-American subjects; however, many of these SNPs (rs9493873 near SGK1, rs3095748 in DAPK1, rs2043599 near NLRP8 and NLRP13, rs10517025 in ATP8A1, and rs17221323 in DIP2C) failed to reach genome-wide significance during our sensitivity analyses, indicating that these associations were likely driven by extremely high or low IFNa secretion measured in only a few subjects homozygous for the minor allele. Thus, these associations should be interpreted with caution.
Of particular interest with IL-6 is our finding that individuals heterozygous (GA) at rs2255327 in BLK, the B lymphoid tyrosine kinase, had levels of IL-6 two-fold higher than those homozygous for the major allele (GG). In addition to B cells, BLK is also expressed in granulocytes, monocytes, and macrophages (Okutani et al. 2006) . BLK plays a critical role in B cell receptor signaling and subsequent development. Related Src family kinases activate cytokine production (IL-1, IL-6, TNFa) in macrophages in response to pathogen recognition by TLRs (Lowell 2004) . SNPs in BLK are associated with autoimmune and inflammatory disorders such as systemic lupus erythematosum (Harley et al. 2008; Ito et al. 2009; Yang et al. 2009 ), Sjogren's syndrome (Nordmark et al. 2011) , systemic sclerosis (Gourh et al. 2010) , and antiphospholipid antibody syndrome (Yin et al. 2009 ). Our results indicate that genetic variation in BLK may affect downstream IL-6 production.
We found a number of SNPs located near (rs16850885) or within (rs16850864, rs572987) the MTHFD2L gene associated with variations in IL-1b secretion in our Caucasian subjects. MTHFD2L codes for a methylenetetrahydrofolate dehydrogenase 2-like protein involved in carbon metabolism and conversion of folate to formate in the mitochondria (Bolusani et al. 2011) . As shown in Fig. 2 , these SNPs are all in tight LD with one another. Another nearby SNP, rs7694828, is in tight LD with each of these * Sensitivity analysis p values are as follows: r rs10195263 = 5.51E-10, rs8012779 = 3.09E-06, rs4078978 = 3.9E-30, rs17252936 = 3.98E-07, rs6778194 = 9.5E-07, rs2272205 = 3.75E-07, rs4713226 = 4.62E-06, rs13067593 = 2.42E-07, rs17221323 = 3.18E-06, rs4839431 = 6.78E-06, rs10517025 = 3.33E-06, rs9493873 = 5.03E-06, rs3095748 = 9.4E-06, rs2043599 = (Kim et al. 2007) . CTCF functions as an insulator, preventing the influence of cis-acting enhancers on gene activation (Bell et al. 1999 ). Yet another SNP (rs10014791) is also in high LD (r 2 = 1) with the three identified MTHFD2L SNPs and resides in a binding site for v-MAF. Thus, the identified SNPs may not directly affect the associated immune outcome, but rather tag nearby SNPs whose functional effects lead to variations in the downstream immune outcome. Most of the SNPs reported here are non-coding SNPs. This is due, in large part, to the composition of the HumanHap 550/650 chips: the vast majority of the SNPs on these platforms are in non-coding regions of the genome. Noncoding SNPs in splice sites, promoters, and regulatory regions can have as profound an influence on gene expression/function as coding SNPs; furthermore, the SNPs we have identified may not be the causal SNPs, but rather tag coding/regulatory SNPs that actually impact gene/protein expression or function. We view this initial GWAS as a screening tool to identify genetic regions of interest for the future replication and fine-mapping efforts that we believe will be critical to elucidating the mechanisms behind the reported genetic associations. Our study utilized individuals with documented evidence of vaccinia immunization, simultaneously analyzed multiple cytokines involved in both innate and adaptive responses to poxviruses, and allowed us to assess associations within genetically defined racial subgroups. However, our study was limited in that (1) we had a relatively small number of African-American subjects, (2) we examined a large, but not comprehensive, set of cytokines, and (3) we do not yet have an external validation data set. With these limitations in mind, we have nevertheless identified a number of novel genes containing SNPs associated with vaccinia-specific cytokine responses to smallpox vaccination. These SNPs are found in genes with known immune function, as well as in genes with no previously identified connection to immune responses, and in intergenic regions of the genome. We examined each significant (p \ 5 9 10 -7 ) race-specific association in the other racial group in a preliminary manner, using a cut-off of p \ 0.01 in the second racial group. While we found a number of SNPs associated with similar trends in immune p values were adjusted for gender, age quartile at enrollment, time from immunization to blood draw, season and temperature sample was sent, time from blood draw to assay in quartiles, and the first four eigenvectors from the principal component analysis outcome, we did not find any SNP associations that reached this significance threshold. This initial replication assessment was likely hampered by racial effects and low sample sizes. Thus, important next steps are to expand the selection of cytokines examined (such as IL-17), finemapping to identify causal variants (both coding and regulatory), replication of the identified associations and fine-mapped variants in an independent cohort. Our findings may pinpoint novel means of immune regulation, and these newly identified SNPs may be excellent candidates for functional studies aimed at discovering the mechanisms behind such regulation. 
